Equities

Shanghai Rightongene Biotechnology Co Ltd

688217:SHH

Shanghai Rightongene Biotechnology Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)23.90
  • Today's Change0.10 / 0.42%
  • Shares traded190.94k
  • 1 Year change-41.45%
  • Beta--
Data delayed at least 15 minutes, as of May 31 2024.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Shanghai Rightongene Biotechnology Co Ltd is a China-based company principally engaged in the research and development, production and sales of in-vitro diagnostic products, as well as the provision of scientific research and testing services. The Company's main products include leukemia molecular diagnostic kits and lymphoma molecular diagnostic kits. The Company mainly provides precise gene and antigen testing services for patients with blood diseases, solid tumors and infectious diseases. The Company also provides scientific research services applied in basic research, disease typing, drug adaptability and target genetic testing. The Company mainly conducts its businesses within domestic market.

  • Revenue in CNY (TTM)265.52m
  • Net income in CNY7.17m
  • Incorporated2012
  • Employees501.00
  • Location
    Shanghai Rightongene Biotechnology Co Ltd#6055 Jinhai ExpresswayFengxian District, Building 3Shanghai 201403ChinaCHN
  • Phone+86 2 133282601
  • Fax+86 2 137199015
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Hangzhou Tianmushan Phrmtcl ntrprs C Ltd137.86m-38.94m988.84m380.00--36.07--7.17-0.3198-0.31981.130.22510.46192.303.90362,781.80-13.21-6.93-54.44-18.9221.1633.95-28.59-16.420.5282-4.370.6609--11.82-19.4243.35---24.89--
AVE Science & Technology Co Ltd206.22m24.46m1.07bn492.0043.842.17--5.200.35970.35973.037.280.37952.0433.65419,148.404.507.214.928.1855.6958.9311.8615.485.60--0.0022.461.795.8819.81-4.62-23.68--
Shanghai Rendu Biotechnology Co Ltd170.46m18.36m1.26bn358.0068.491.31--7.380.45890.45894.2623.900.16181.122.16476,147.801.746.261.887.1780.8074.3610.7714.5411.85--0.00667.96-45.8918.85-64.60--23.48--
Shanghai Rightongene Biotechnlgy Co Ltd265.52m7.17m1.33bn501.00179.461.43--5.030.13320.13324.7516.670.25401.091.40529,970.30-0.09014.16-0.0984.4975.0270.45-0.354811.6210.43--0.02845.90-39.142.84-80.41-11.4619.65--
Shaanxi Kanghui Pharmaceutical Co Ltd676.54m-33.28m1.39bn952.00--1.46--2.05-0.3332-0.33326.779.510.34772.873.56710,646.30-3.16-0.1562-4.44-0.199126.5840.00-9.10-0.49070.6901-0.35690.366595.1536.9212.3758.52--66.95--
Shanghai Serum Bio-Technology Co Ltd192.49m37.23m1.44bn321.0038.661.32--7.480.34410.34411.7810.050.16890.92826.82599,656.403.2710.433.3210.8475.0880.5419.3432.5750.03--0.011964.939.145.67-39.54-1.6213.07--
Guangzhou LBP Medicine Scnc&Tech Co Ltd508.01m40.23m1.60bn907.0039.891.26--3.150.42920.42925.3213.610.37192.122.15560,104.201.835.101.915.5567.8375.154.9112.976.70--0.006824.42-1.9910.18-6.18-8.21-2.98--
Data as of May 31 2024. Currency figures normalised to Shanghai Rightongene Biotechnology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

15.35%Per cent of shares held by top holders
HolderShares% Held
Rongtong Fund Management Co., Ltd.as of 31 Dec 20232.06m5.62%
E Fund Management Co., Ltd.as of 31 Dec 2023973.84k2.65%
Orient Securities Asset Management Co. Ltd.as of 31 Dec 2023875.84k2.38%
Gfund Management Co., Ltd.as of 31 Dec 2023435.36k1.19%
Da Cheng Fund Management Co., Ltd.as of 31 Dec 2023347.05k0.95%
Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2023331.85k0.90%
China Asset Management Co., Ltd.as of 31 Dec 2023220.26k0.60%
Goldstate Capital Fund Management Co., Ltd.as of 31 Dec 2023206.29k0.56%
Broad Fund Management Co. Ltd.as of 31 Dec 2023108.85k0.30%
China Universal Asset Management Co., Ltd.as of 31 Dec 202375.90k0.21%
More ▼
Data from 30 Jun 2023 - 29 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.